SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Pursuant to
Section 13 or 15(d) of
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): July 30, 2004
STEMCELLS, INC.
| Delaware | 0-19871 | 94-3078125 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
3155 Porter Drive
Palo Alto, California 94304
(650) 475-3100
| Item 7. Financial Statements, Pro Forma Financial Information And Exhibits. | ||||||||
| Item 12. Results of Operations and Financial Condition. | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits — The following exhibit is furnished as part of this Report.
| Exhibit | ||
| Number |
Description |
|
99.1
|
Press Release dated July 30, 2004. |
Item 12. Results of Operations and Financial Condition.
On July 30, 2004, StemCells, Inc. (the “Company”) issued a press release reporting the Company’s financial results for the second quarter of fiscal year 2004 (the “Press Release”). The Press Release is being furnished as Exhibit 99.1 to this Report.
The information being furnished under this Item 12 shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities and Exchange Act of 1934, except as shall be expressly set forth by specific reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| STEMCELLS, INC. |
||||
| By: | /s/ Martin McGlynn | |||
| Martin McGlynn | ||||
| President and Chief Executive Officer | ||||
Date: July 30, 2004